Gregory Kathryn

Director Gregory Kathryn buys 1,260 shares of CTCX at $0.51; stock down 90.4% from 52-week high, 5-trade cluster pattern in past 14 days.

Gregory Kathryn (Director) purchased 1,260 shares at $0.51 on 2024-09-06, increasing holdings by 5.9% to 22,500 shares. The purchase occurs amid severe price pressure: CTCX trades at $0.47 current price, representing a 90.4% decline from its 52-week high of $4.87, with a 77.5% drop over 90 days. The company is unprofitable with a net income of $-3,304,538.00 for its most recent full fiscal year and latest quarterly revenue of $12,320.00 against a $9,825,541.29 market cap. Notably, five other insiders also bought within the past 14 days, establishing a cluster pattern. Kathryn's cross-ticker track record shows mixed outcomes (18 prior buys, 30-day average +5.3%, 90-day average -15.9%, 90-day win rate 30.00%), while his five recent CTCX purchases (2024-08-26 through 2024-08-30) remain too recent for outcome measurement. The timing of this cluster buy during a sustained decline in a distressed equity warrants scrutiny of the underlying business rationale.

Director Gregory Kathryn buys 109 CTCX shares at $0.57; stock down -88.5% from 52-week high, -50.0% in 30 days, amid cluster of 5 other insider buys.

Gregory Kathryn purchased 109 shares on 2024-08-30 at $0.57, bringing holdings to 21,240 shares. The purchase occurs within a 5-day span of consecutive insider buys at the same ticker (2024-08-23 through 2024-08-30), with 5 other insiders also buying within the past 14 days. CTCX trades at $0.56 currently, down -88.5% from its 52-week high of $4.87 and down -50.0% over the past 30 days. The company reported $12.3K in latest quarterly revenue against a net loss of $-3.3M and operates at a $11.7M market cap while unprofitable. Across Gregory's cross-ticker track record, 17 prior buys averaged -15.9% return over 90 days with a 30.00% win rate, providing limited precedent for timing accuracy. The cluster buy pattern and consecutive purchases at a severely depressed valuation warrant observation of underlying catalysts or circumstances motivating simultaneous insider acquisition.

Director Gregory Kathryn bought 1,736 shares at $0.56 across 2 transactions; stock down 86.9% from 52-week high amid cluster buying by 6 other insiders.

Gregory Kathryn, a Director, executed 2 separate purchases totaling 1,736 shares (1.7K shares) for $972.16, raising her holdings by 9.0% to 21,131 shares (21.1K shares). The transactions occurred at $0.56 per share on 2024-08-28 and 2024-08-29, while the current price stands at $0.64, reflecting a sharp decline of 86.9% from the 52-week high of $4.87 and a 74.3% drop over the past 90 days. The company reported net income of $-3.3M in its most recent full fiscal year, indicating ongoing unprofitability. The filing reveals a cluster pattern, with 6 other insiders also buying within the past 14 days, though the significance of this coordinated activity is limited by the company's fundamental weakness and the stock's severe price deterioration.

Director Gregory Kathryn bought 2,413 shares of CTCX at $0.71 on 2024-08-27; stock now -88.7% from 52-week high amid cluster buying.

Director Gregory Kathryn purchased 2,413 shares at $0.71 on 2024-08-27, increasing holdings by 14.2% to 19,395 shares post-transaction. The stock has deteriorated sharply, trading at $0.55 current price with a -88.7% decline from its 52-week high of $4.87 and a -77.9% drop over 90 days. Fundamentally, the company reported $12.3K in latest quarterly revenue against a $-3.3M net loss, with an $11.5M market cap and unprofitable full-year results. This buy occurs as part of a cluster pattern—6 other insiders also purchased within the past 14 days—yet at Carmell Corp specifically, all 5 of the insider's prior open-market trades at this ticker remain too recent to show measurable outcome data, and his cross-ticker track record shows only a 30.00% 90-day win rate. The confluence of severe price deterioration, negative fundamentals, small scale transaction ($1.7K), and unproven same-ticker track record suggests this activity warrants monitoring for context but carries limited information density.

Director Gregory Kathryn purchased 4,826 shares at $0.72 across two dates; stock now trades at $0.71, down 85.4% from 52-week high.

Gregory Kathryn (Director) executed 2 separate purchases totaling 4,826 shares for $3,474.72, increasing holdings from 12.2K to 17.0K shares (+39.7%). The trades occur in a stock trading near its 52-week low of $0.70, down 85.4% from the $4.87 peak and down 29.0% over the prior 30 days. At the same ticker, the insider's prior 3 measurable buys (Dec 2023) showed negative 90-day returns of -10.6%, -2.6%, and -36.8%, with 0 of 3 proving well-timed. The company reported latest-quarter revenue of $12.3K and net income of $-3.3M, reflecting persistent unprofitability. A cluster pattern is present: 2 other insiders bought within the past 14 days. While the director is accumulating at depressed valuations, the prior same-ticker purchase timing pattern and negative fundamentals present headwinds to near-term recovery.

Director Gregory Kathryn purchased 5,429 shares ($4.1K) at blended avg $0.76; stock down -85.2% from 52-week high, -72.0% in 90 days.

Gregory Kathryn, a director, made 2 separate purchases totaling 5,429 shares for $4,126.03, raising her holdings from 6,727 to 12,156 shares (+80.7% increase). The purchases occurred at prices of $0.79 and $0.72 across two consecutive trading days, with the current price at $0.72 representing an -85.2% decline from the 52-week high of $4.87. At the same ticker, her prior 4 measurable buy transactions all posted negative 90-day returns (ranging from -22.3% to -57.6%), with zero occurrences of positive post-purchase outcomes over that period. The company posted a net loss of $3,304,538 on quarterly revenue of $12,320, indicating severe operational distress. While a cluster buy pattern is present (2 other insiders also acquired within the past 14 days), the director's repeated pattern of adverse 90-day returns at this ticker, combined with the company's loss-making status, provides no affirmative signal for investors.